![]() |
long distances. Maintaining hydration and electrolyte balance is therefore a major concern for riders and veterinarians.
As a result, administering intravenous (IV) fluids before competition has become increasingly common, especially at major endurance events where horses are expected to compete in high temperatures, over difficult terrain, or under conditions that increase the risk of dehydration.
Despite its popularity, however, there has been little scientific evidence to show whether pre-ride IV fluids actually improve hydration, reduce cardiovascular strain, or enhance performance.
To investigate this question, Laura Weintraub and colleagues at Loomis Basin Equine Medical Center, Penryn, California, conducted a study to determine whether administering intravenous fluids before an endurance competition provides measurable physiological or clinical benefits. Their findings have been published in the Journal of Equine Veterinary Science.
The researchers hypothesised that horses receiving IV fluids the day before competition would be better hydrated and experience less cardiovascular stress than untreated horses. They expected the treated horses to have lower heart rates during the ride together with laboratory findings consistent with improved hydration.
Fourteen client-owned horses entered in a 45 km endurance ride were enrolled in the study. The event was held in extreme heat over challenging terrain, providing an ideal opportunity to assess whether additional fluid support offered any advantage.
The horses were randomly assigned to one of two groups. One group received intravenous fluids the day before the ride, while the control group received no fluid treatment.
Data were collected at six time points: before travelling from home, at check-in the day before the ride, two to three hours after catheterisation and treatment, one hour before the start, 32 km into the ride, and immediately after finishing.
At each assessment, the horses underwent physical examination and blood sampling. Laboratory measurements included bicarbonate, sodium, potassium, chloride, calcium, glucose, lactate, blood urea nitrogen (BUN), creatinine, packed cell volume and total protein. The results were analysed using two-way analysis of variance (ANOVA).
The researchers found only minor differences between the two groups.
Horses that received IV fluids had lower total protein concentrations shortly after treatment, reflecting the expected short-term dilution of the blood following fluid administration. Blood urea nitrogen concentrations were also lower in the treated horses at the 32 km checkpoint, suggesting a modest effect on hydration status or kidney-related blood parameters during exercise.
However, these changes did not translate into clinically meaningful benefits.
Heart rate, one of the most important indicators of cardiovascular effort and recovery in endurance horses, was similar in both groups. Horses receiving IV fluids had a mean heart rate of 36 ± 5 beats per minute compared with 39 ± 3 beats per minute in the untreated horses, a difference that was not statistically significant.
Overall, the study suggests that while pre-competition IV fluids can produce measurable changes in some blood parameters, these changes are small and may have little practical significance. The reduction in total protein reflects temporary haemodilution rather than improved fitness for exercise, while the lower BUN concentration observed during the ride was not accompanied by improved cardiovascular responses or other indicators of enhanced performance.
The findings therefore challenge the assumption that routinely administering intravenous fluids before competition benefits healthy endurance horses. In this study, pre-ride fluid therapy did not reduce cardiovascular strain, improve heart-rate recovery, or produce widespread improvements in laboratory markers of hydration.
For veterinarians, riders and event organisers, the study provides valuable evidence when considering the routine use of pre-competition IV fluids. Fluid therapy requires veterinary supervision, venous catheterisation, specialised equipment and additional time. If it offers little measurable benefit in healthy horses, its routine use as a preventive hydration strategy may not be justified.
These findings do not mean intravenous fluids are never appropriate. Horses showing clinical signs of dehydration, heat stress, illness or poor recovery may still require fluid therapy as part of their veterinary treatment. However, this study suggests that administering IV fluids simply because a horse is about to tackle a demanding endurance ride may provide far less benefit than many riders and veterinarians have assumed.
For more details, see:
Weintraub, L., Fielding, C. L., Carli, I., & Greene-Dittz, G.
The effect of intravenous fluids administered prior to competition: A randomized clinical trial.
Journal of Equine Veterinary Science,(2026) 106121.





